# Sanara MedTech Inc.: filings

SMTI · Nasdaq · CIK 714256 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/smti.md) · [Financials](/companies/smti/financials.md) · [Filings](/companies/smti/filings.md) · [Insiders](/companies/smti/insiders.md)

## Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 174, 8-K 165, 10-Q 53, 3 31, 425 21, 10-K 18, CORRESP 12, DEFA14A 10, UPLOAD 10, 8-K/A 9, NT 10-Q 9, DEF 14A 8, NT 10-K 8, SC 13D/A 8, D 5, 10-K/A 4, 4/A 4, ARS 4, 10-Q/A 3, 3/A 3, 424B5 3, 5 3, S-8 3, SC 13D 3, SC 13G 3, EFFECT 2, PRE 14A 2, S-3 2, SC 13G/A 2, SCHEDULE 13G/A 2, 8-A12B 1, CERT 1, DEF 14C 1, DEFM14A 1, PRE 14C 1, PRER14A 1, RW 1, S-8 POS 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:15 ET | [8-K](/filings/0001493152-26-049275.md) | 7.01 Regulation FD disclosure | 0001493152-26-049275 |
| 2026-10-16 | 09:20 ET | [8-K](/filings/0001213900-26-110053.md) | 8.01 Other events | 0001213900-26-110053 |
| 2026-10-01 | 19:48 ET | [8-K](/filings/0001213900-26-105390.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001213900-26-105390 |
| 2026-08-11 | 17:08 ET | [10-Q](/filings/0001493152-26-037176.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037176 |
| 2026-08-11 | 16:10 ET | [8-K](/filings/0001493152-26-037131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037131 |
| 2026-08-11 | 16:05 ET | [8-K/A](/filings/0001493152-26-037112.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037112 |
| 2026-07-29 | 16:21 ET | [8-K](/filings/0001493152-26-035196.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035196 |
| 2026-06-09 | 16:15 ET | [8-K](/filings/0001493152-26-027936.md) | 5.07 Shareholder vote results | 0001493152-26-027936 |
| 2026-06-04 | 16:15 ET | [8-K](/filings/0001493152-26-027274.md) | 1.02 Termination of a material agreement | 0001493152-26-027274 |
| 2026-05-12 | 16:03 ET | [10-Q](/filings/0001493152-26-022479.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022479 |
| 2026-05-11 | 17:21 ET | [8-K](/filings/0001493152-26-022291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022291 |
| 2026-04-17 | 07:30 ET | [DEF 14A](/filings/0001493152-26-017156.md) | Proxy statement, period 2025-12-31 | 0001493152-26-017156 |
| 2026-03-24 | 16:02 ET | [10-K](/filings/0001493152-26-012352.md) | Annual report, period 2025-12-31 | 0001493152-26-012352 |
| 2026-03-24 | 07:10 ET | [8-K](/filings/0001493152-26-012266.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012266 |
| 2026-03-02 | 16:11 ET | [8-K](/filings/0001493152-26-008547.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008547 |
| 2026-01-23 | 07:45 ET | [8-K](/filings/0001493152-26-003316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-003316 |
| 2025-11-26 | 16:10 ET | [8-K](/filings/0001493152-25-025152.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025152 |
| 2025-11-12 | 16:03 ET | [10-Q](/filings/0001493152-25-021894.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021894 |
| 2025-11-12 | 07:05 ET | [8-K](/filings/0001493152-25-021715.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021715 |
| 2025-11-12 | 06:06 ET | [8-K](/filings/0001493152-25-021615.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021615 |
| 2025-09-02 | 16:43 ET | [8-K](/filings/0001493152-25-012560.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012560 |
| 2025-08-13 | 09:15 ET | [10-Q](/filings/0001493152-25-011885.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011885 |
| 2025-08-13 | 07:05 ET | [8-K](/filings/0001493152-25-011878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011878 |
| 2025-05-28 | 08:15 ET | [8-K](/filings/0001641172-25-012607.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012607 |
| 2025-05-23 | 16:15 ET | [8-K](/filings/0001641172-25-012267.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-012267 |
| 2025-05-14 | 16:02 ET | [10-Q](/filings/0001641172-25-010254.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010254 |
| 2025-05-14 | 07:15 ET | [8-K](/filings/0001641172-25-010097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010097 |
| 2025-04-22 | 16:48 ET | [8-K](/filings/0001641172-25-005713.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005713 |
| 2025-04-21 | 16:15 ET | [DEF 14A](/filings/0001641172-25-005554.md) | Proxy statement, period 2024-12-31 | 0001641172-25-005554 |
| 2025-04-04 | 16:30 ET | [8-K](/filings/0001641172-25-002780.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002780 |
| 2025-03-25 | 17:23 ET | [10-K](/filings/0001641172-25-000632.md) | Annual report, period 2024-12-31 | 0001641172-25-000632 |
| 2025-03-25 | 07:05 ET | [8-K](/filings/0001641172-25-000506.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000506 |
| 2025-01-22 | 16:26 ET | [8-K](/filings/0001493152-25-003236.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-003236 |
| 2025-01-22 | 16:21 ET | [8-K](/filings/0001493152-25-003234.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003234 |
| 2025-01-21 | 16:15 ET | [8-K](/filings/0001493152-25-003043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-003043 |
| 2024-12-04 | 07:30 ET | [8-K](/filings/0001493152-24-048602.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-048602 |
| 2024-11-12 | 17:05 ET | [8-K](/filings/0001493152-24-044829.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044829 |
| 2024-11-12 | 16:02 ET | [10-Q](/filings/0001493152-24-044737.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044737 |
| 2024-10-07 | 16:05 ET | [8-K](/filings/0001493152-24-040275.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-040275 |
| 2024-09-23 | 16:31 ET | [8-K](/filings/0001493152-24-037820.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-037820 |
| 2024-09-11 | 16:05 ET | [8-K](/filings/0001493152-24-035783.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035783 |
| 2024-08-12 | 16:44 ET | [8-K](/filings/0001493152-24-031301.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031301 |
| 2024-08-12 | 16:02 ET | [10-Q](/filings/0001493152-24-031254.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031254 |
| 2024-06-20 | 09:00 ET | [8-K](/filings/0001493152-24-024438.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024438 |
| 2024-06-18 | 16:05 ET | [8-K](/filings/0001493152-24-024275.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-024275 |
| 2024-06-17 | 17:07 ET | [8-K](/filings/0001493152-24-024163.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024163 |
| 2024-05-30 | 16:15 ET | [8-K](/filings/0001493152-24-021982.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-021982 |
| 2024-05-13 | 16:09 ET | [10-Q](/filings/0001493152-24-018880.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018880 |
| 2024-05-13 | 09:20 ET | [8-K](/filings/0001493152-24-018808.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-018808 |
| 2024-04-18 | 09:20 ET | [8-K](/filings/0001493152-24-015133.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-015133 |

Page 1 of 6. [Older](/companies/smti/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:18 ET. No prices; not investment advice.